These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study. Tardif JC, Ponikowski P, Kahan T, ASSOCIATE Investigators. Int J Cardiol; 2013 Sep 30; 168(2):789-94. PubMed ID: 23138014 [Abstract] [Full Text] [Related]
6. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K, INITIATIVE Investigators. Eur Heart J; 2005 Dec 30; 26(23):2529-36. PubMed ID: 16214830 [Abstract] [Full Text] [Related]
7. [A possibility to interchange heart rate-slowing therapy with ivabradine and atenolol in patients with stable angina pectoris]. Shavarov AA, Kiiakbaev GK, Kobalava ZhD. Ter Arkh; 2013 Dec 30; 85(4):77-83. PubMed ID: 23808298 [Abstract] [Full Text] [Related]
8. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Borer JS, Fox K, Jaillon P, Lerebours G, Ivabradine Investigators Group. Circulation; 2003 Feb 18; 107(6):817-23. PubMed ID: 12591750 [Abstract] [Full Text] [Related]
9. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study. Müller-Werdan U, Stöckl G, Ebelt H, Nuding S, Höpfner F, Werdan K, ADDITIONS Study Investigators. Exp Gerontol; 2014 Nov 18; 59():34-41. PubMed ID: 25193811 [Abstract] [Full Text] [Related]
10. Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina. Amosova E, Andrejev E, Zaderey I, Rudenko U, Ceconi C, Ferrari R. Cardiovasc Drugs Ther; 2011 Dec 18; 25(6):531-7. PubMed ID: 21830063 [Abstract] [Full Text] [Related]
11. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study. Oh PC, Kang WC, Moon J, Park YM, Kim S, Kim MG, Lee K, Ahn T, Shin EK. Am J Cardiovasc Drugs; 2016 Jun 18; 16(3):221-8. PubMed ID: 27021556 [Abstract] [Full Text] [Related]
14. Ivabradine improves all aspects of quality of life assessed with the 36-item short form health survey in subjects with chronic ischemic heart disease compared with beta-blockers. Riccioni G, Prencipe G, Benvenuto A, Masciocco L, Ventra S, Rizzo U, Russi C, Speziale G. Pharmacology; 2013 Jun 18; 91(1-2):35-8. PubMed ID: 23146926 [Abstract] [Full Text] [Related]
15. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris. Rousseau MF, Pouleur H, Cocco G, Wolff AA. Am J Cardiol; 2005 Feb 01; 95(3):311-6. PubMed ID: 15670536 [Abstract] [Full Text] [Related]
18. Effectiveness of Ivabradine in Treating Stable Angina Pectoris. Ye L, Ke D, Chen Q, Li G, Deng W, Wu Z. Medicine (Baltimore); 2016 Apr 01; 95(14):e3245. PubMed ID: 27057864 [Abstract] [Full Text] [Related]